What is the current Anorexiants Market size?

The Anorexiants Market is projected to register a CAGR of 3.9% during the forecast period (2024-2029) Read More

Who are the key players in Anorexiants Market?

Novo Nordisk Inc.,, Lannett Co, Inc., F. Hoffmann-La Roche AG, Pfizer Inc. and Currax Pharmaceuticals LLC are the major companies operating in the Anorexiants Market. Read More

Which is the fastest growing region in Anorexiants Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Anorexiants Market?

In 2024, the North America accounts for the largest market share in Anorexiants Market. Read More

What years does this Anorexiants Market cover?

The report covers the Anorexiants Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Anorexiants Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Anorexiants Market Share

Statistics for the 2023 & 2024 Anorexiants market share, created by Mordor Intelligence™ Industry Reports. Anorexiants share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Anorexiants Industry

The Anorexiants Market is moderately competitive and consists of several major players. Few of the major players are implementing various strategies like increased investments in R&D and mergers & acquisitions. For instance, in September 2019, Currax Pharmaceuticals LLC, acquired Nalpropion Pharmaceuticals, a biopharmaceutical company focused on the treatment of weight loss. With the acquisition deal, Currax has owned the world-wide rights to Contrave, the number one prescription weight-loss brand medication in the United States and Europe. Strategic alliances such as these are expected to boost the sales globally. Some of the companies currently dominating the market are Novo Nordisk Inc., Lannett Co. Inc., Currax Pharmaceuticals LLC, F. Hoffmann-La Roche AG, and Pfizer Inc.